GutID™
Gut health optimization & personalized insights
Key Facts
About Intus Biosciences
Intus Biosciences is an early-stage biotech leveraging a proprietary AI-powered platform, Titan-1™, to analyze the human microbiome at an unprecedented strain-level resolution. The company's technology is positioned to enable breakthroughs in non-invasive diagnostics, particularly for early cancer detection and chronic diseases, by transforming complex microbiome data into actionable health intelligence. While currently private and likely pre-revenue, Intus Bio is actively engaging in research collaborations and has launched a direct-to-consumer gut health test, GutID™, as an initial commercial application. Its strategy involves validating its platform through partnerships and publications to ultimately drive adoption in clinical research and precision medicine.
View full company profile